Mitchell & Pahl Private Wealth’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $802K | Buy |
|
|||||
|
2025
Q2 | $692K | Buy |
|
|||||
|
2025
Q1 | $578K | Buy |
|
|||||
|
2024
Q4 | $665K | Buy |
|
|||||
|
2024
Q3 | $652K | Buy |
|
|||||
|
2024
Q2 | $652K | Buy |
|
|||||
|
2024
Q1 | $838K | Buy |
|
|||||
|
2023
Q4 | $700K | Buy |
|
|||||
|
2023
Q3 | $578K | Buy |
|
|||||
|
2023
Q2 | $523K | Buy |
|
|||||
|
2023
Q1 | $461K | Buy |
|
|||||
|
2022
Q4 | $486K | Buy |
|
|||||
|
2022
Q3 | $405K | Buy |
|
|||||
|
2022
Q2 | $417K | Buy |
|
|||||
|
2022
Q1 | $349K | Buy |
|
|||||
|
2021
Q4 | $397K | Buy |
|
|||||
|
2021
Q3 | $328K | Buy |
|
|||||
|
2021
Q2 | $289K | Buy |
|